Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.11B |
| 2 |
NVIDIA
NVDA
|
+$2.59B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$2.58B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$2.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.21B |
| 2 |
Lam Research
LRCX
|
+$976M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$771M |
| 4 |
Warner Bros
WBD
|
+$771M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$710M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.73% |
| 2 | Financials | 9.04% |
| 3 | Consumer Discretionary | 7.38% |
| 4 | Healthcare | 7.28% |
| 5 | Industrials | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Essent Group
ESNT
$6.12B
| $46.9M | 0.01% |
802,002
+196,769
| +33% | +$12M |
|
1627
iShares US Energy ETF
IYE
$1.71B
| $46.8M | 0.01% |
722,662
| – | – |
|
1628
Aehr Test Systems
AEHR
$2.52B
| $46.8M | 0.01% |
1,262,043
+1,086,001
| +617% | +$34.7M |
|
1629
Manhattan Associates
MANH
$9.42B
| $46.6M | 0.01% |
349,915
+1,149
| +0.3% | +$172K |
|
1630
Eastman Chemical
EMN
$7.74B
| $46.6M | 0.01% |
610,150
+205,281
| +51% | +$14.8M |
|
1631
Assured Guaranty
AGO
$3.78B
| $46.6M | 0.01% |
571,350
+142,524
| +33% | +$12.2M |
|
1632
PUT
KLA
KLAC
$266B
| $46.5M | 0.01% |
316,000
-311,000
| -50% | -$45.5M |
|
1633
Energy Fuels
UUUU
$2.93B
| $46.5M | 0.01% |
2,548,028
+1,331,211
| +109% | +$27.6M |
|
1634
PUT
Coinbase
COIN
$44.1B
| $46.4M | 0.01% |
265,900
-118,100
| -31% | -$23.2M |
|
1635
Home BancShares
HOMB
$6.21B
| $46.4M | 0.01% |
1,723,570
+247,961
| +17% | +$6.98M |
|
1636
NMI Holdings
NMIH
$3.27B
| $46.4M | 0.01% |
1,236,763
+275,167
| +29% | +$10.7M |
|
1637
Braze
BRZE
$2.65B
| $46.4M | 0.01% |
1,964,053
+1,029,525
| +110% | +$22.3M |
|
1638
PUT
Expedia Group
EXPE
$33.4B
| $46.4M | 0.01% |
200,800
+70,000
| +54% | +$17.2M |
|
1639
Axcelis
ACLS
$3.94B
| $46.3M | 0.01% |
497,624
-132,190
| -21% | -$11.7M |
|
1640
Arcosa
ACA
$7.14B
| $46.2M | 0.01% |
435,101
-98,538
| -18% | -$11.2M |
|
1641
Herbalife
HLF
$1.26B
| $46.1M | 0.01% |
3,133,436
+684,850
| +28% | +$11.2M |
|
1642
Ingredion
INGR
$6.4B
| $46.1M | 0.01% |
409,215
+269,217
| +192% | +$30.9M |
|
1643
CALL
ASML
ASML
$636B
| $46.1M | 0.01% |
34,900
-7,000
| -17% | -$9.59M |
|
1644
Timken Company
TKR
$9.81B
| $46M | 0.01% |
457,735
+323,233
| +240% | +$32.1M |
|
1645
Neurocrine Biosciences
NBIX
$17.7B
| $46M | 0.01% |
349,179
-15,356
| -4% | -$2.04M |
|
1646
Dianthus Therapeutics
DNTH
$5.71B
| $46M | 0.01% |
548,010
-29,009
| -5% | -$1.68M |
|
1647
Kaspi.kz JSC
KSPI
$16.4B
| $45.8M | 0.01% |
617,739
+196,022
| +46% | +$14.8M |
|
1648
VF Corp
VFC
$6.72B
| $45.7M | 0.01% |
2,687,686
+1,388,532
| +107% | +$26.2M |
|
1649
CALL
Roku
ROKU
$21.2B
| $45.7M | 0.01% |
482,600
-98,700
| -17% | -$9.61M |
|
1650
Vera Therapeutics
VERA
$2.53B
| $45.6M | 0.01% |
1,133,969
+13,189
| +1% | +$568K |
|
Similar funds
Goldman Sachs's Q1 2026 Portfolio in Review
As of Q1 2026, Goldman Sachs held 7,166 positions worth $871B, up 6.8% from $815B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs deployed $86.3B of net new capital in Q1 2026, opening 752 new positions and adding to 3,118 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, an estimated $1.21B trimmed.
- Goldman Sachs's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
- Goldman Sachs added most to Microsoft in Q1 2026, an estimated $4.11B increase.
- Goldman Sachs's biggest Q1 2026 reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, cutting an estimated $1.21B.
- Goldman Sachs fully exited Dayforce in Q1 2026, selling an estimated $441M.
- Goldman Sachs's ten largest holdings make up 20% of its $871B portfolio in Q1 2026.
- Goldman Sachs opened 752 new positions and closed 735 in Q1 2026.
- Goldman Sachs's portfolio value rose 6.8% quarter-over-quarter to $871B.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.